Outcomes of transvenous lead extraction in octogenarians using bidirectional rotational mechanical sheaths

Background Outcomes of transvenous lead extraction (TLE) are well reported in the general population, However, data on safety, efficacy of TLE in octogenarians with a long lead dwell time, using powered extraction tools are limited. The aim of this multicenter study was to evaluate the safety, effec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pacing and clinical electrophysiology 2023-08, Vol.46 (8), p.960-968
Hauptverfasser: Migliore, Federico, Pittorru, Raimondo, Dall'Aglio, Pietro Bernardo, De Lazzari, Manuel, Falzone, Pasquale Valerio, Sottini, Simone, Dentico, Alessia, Ferrieri, Alessandra, Pradegan, Nicola, Bertaglia, Emanuele, Iliceto, Sabino, Gerosa, Gino, Tarzia, Vincenzo, Carretta, Domenico
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Outcomes of transvenous lead extraction (TLE) are well reported in the general population, However, data on safety, efficacy of TLE in octogenarians with a long lead dwell time, using powered extraction tools are limited. The aim of this multicenter study was to evaluate the safety, effectiveness of TLE in octogenarians using the bidirectional rotational mechanical sheaths and mid‐term outcome after TLE. Methods The study population comprised 83 patients (78.3% male; mean age 85 ± 3 years; [range 80–94 years]) with 181 target leads. All the leads (mean implant duration 112 ± 77 months [range 12–377]) were extracted exclusively using the Evolution RL sheaths (Cook Medical, Bloomington, IN, USA). Results The main indication for TLE was infection in 84.3% of cases. Complete procedural success rate, clinical success rate, per lead were 93.9% and 98.3%, respectively. Failure of lead extraction was seen in 1.7% of leads. The additional use of a snare was required in 8.4% of patients. Major complications occurred in one patient (1.2%). Thirty‐day mortality after TLE was 6%. During a mean time follow‐up of 22 ± 21 months, 24 patients (29%) died. No procedure‐related mortality occurred. Predictors of mortality included ischemic cardiomyopathy (HR 4.35; 95% CI 1.87–10.13; p = .001), left ventricularejection fraction ≤35% (HR 7.89; 95% CI 3.20–19.48; p 
ISSN:0147-8389
1540-8159
DOI:10.1111/pace.14696